Esperion Therapeutics Stock Forecast - Price Action Indicator
| ESPR Stock | USD 2.15 0.03 1.42% |
Esperion Stock Forecast is based on your current time horizon. Although Esperion Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Esperion Therapeutics' systematic risk associated with finding meaningful patterns of Esperion Therapeutics fundamentals over time.
Esperion |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.035 | 0.04 |
| Check Esperion Therapeutics Volatility | Backtest Esperion Therapeutics | Information Ratio |
Esperion Therapeutics Trading Date Momentum
| On November 19 2024 Esperion Therapeutics was traded for 2.15 at the closing time. The top price for the day was 2.19 and the lowest listed price was 2.06 . There was no trading activity during the period 0.0. Lack of trading volume on November 19, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.93% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Esperion Therapeutics to competition |
Other Forecasting Options for Esperion Therapeutics
For every potential investor in Esperion, whether a beginner or expert, Esperion Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Esperion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Esperion. Basic forecasting techniques help filter out the noise by identifying Esperion Therapeutics' price trends.Esperion Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Esperion Therapeutics stock to make a market-neutral strategy. Peer analysis of Esperion Therapeutics could also be used in its relative valuation, which is a method of valuing Esperion Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Esperion Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Esperion Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Esperion Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Esperion Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Esperion Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Esperion Therapeutics shares will generate the highest return on investment. By undertsting and applying Esperion Therapeutics stock market strength indicators, traders can identify Esperion Therapeutics entry and exit signals to maximize returns.
Esperion Therapeutics Risk Indicators
The analysis of Esperion Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Esperion Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting esperion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.4 | |||
| Semi Deviation | 3.81 | |||
| Standard Deviation | 4.45 | |||
| Variance | 19.79 | |||
| Downside Variance | 15.75 | |||
| Semi Variance | 14.55 | |||
| Expected Short fall | (3.74) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Esperion Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Esperion Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Esperion Stock
| 0.84 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.8 | GSK | GlaxoSmithKline PLC ADR | PairCorr |
| 0.76 | OGN | Organon | PairCorr |
| 0.7 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.7 | NVS | Novartis AG ADR Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Esperion Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Esperion Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Esperion Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Esperion Therapeutics to buy it.
The correlation of Esperion Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Esperion Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Esperion Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Esperion Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Esperion Stock Analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.